Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report

The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma is a subject of debate. We report a durable complete response in a 62-year-old man Jehovah’s Witness with metastatic clear cell renal cell carcinoma who received two cycles of nivolumab/ipilimumab followed by radi...

ver descrição completa

Detalhes bibliográficos
Main Authors: Tony Zibo Zhuang, Lara Harik, Seth Force, Agreen Hadadi, Mehmet Asim Bilen, Jacqueline T. Brown, Bradley C. Carthon, Jamie Goldman, Omer Kucuk, Viraj A. Master, Bassel Nazha
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2022-12-01
Colecção:Frontiers in Oncology
Assuntos:
renal cell carcinoma
nivolumab
ipilimumab
cytoreductive
oligometastatic
TKI (tyrosine kinase inhibitor)
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2022.949400/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.949400/full

Registos relacionados